These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18503264)

  • 21. QSAR--how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets.
    Gedeck P; Rohde B; Bartels C
    J Chem Inf Model; 2006; 46(5):1924-36. PubMed ID: 16995723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of gastro-intestinal absorption using multivariate adaptive regression splines.
    Deconinck E; Xu QS; Put R; Coomans D; Massart DL; Vander Heyden Y
    J Pharm Biomed Anal; 2005 Oct; 39(5):1021-30. PubMed ID: 16040225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpreting computational neural network QSAR models: a measure of descriptor importance.
    Guha R; Jurs PC
    J Chem Inf Model; 2005; 45(3):800-6. PubMed ID: 15921469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
    Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
    Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel descriptor of amino acids and its application in peptide QSAR.
    Tong J; Liu S; Zhou P; Wu B; Li Z
    J Theor Biol; 2008 Jul; 253(1):90-7. PubMed ID: 18397794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benchmarking of QSAR models for blood-brain barrier permeation.
    Konovalov DA; Coomans D; Deconinck E; Heyden YV
    J Chem Inf Model; 2007; 47(4):1648-56. PubMed ID: 17602606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of MOLMAP approach for QSAR modeling of various biological activities using substituent electronic descriptors.
    Hemmateenejad B; Mehdipour AR; Miri R; Shamsipur M
    J Comput Chem; 2009 Oct; 30(13):2001-9. PubMed ID: 19130500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSTR with extended topochemical atom (ETA) indices. 9. Comparative QSAR for the toxicity of diverse functional organic compounds to Chlorella vulgaris using chemometric tools.
    Roy K; Ghosh G
    Chemosphere; 2007 Nov; 70(1):1-12. PubMed ID: 17765287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSTR with extended topochemical atom (ETA) indices. 12. QSAR for the toxicity of diverse aromatic compounds to Tetrahymena pyriformis using chemometric tools.
    Roy K; Ghosh G
    Chemosphere; 2009 Nov; 77(7):999-1009. PubMed ID: 19709717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive SMILES-based optimal descriptors in QSAR modelling bee toxicity: Using rare SMILES attributes to define the applicability domain.
    Toropov AA; Benfenati E
    Bioorg Med Chem; 2008 May; 16(9):4801-9. PubMed ID: 18395455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of structure-activity relationships in a series of glibenclamide analogues.
    Yuriev E; Kong DC; Iskander MN
    Eur J Med Chem; 2004 Oct; 39(10):835-47. PubMed ID: 15464617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stochastic versus stepwise strategies for quantitative structure-activity relationship generation--how much effort may the mining for successful QSAR models take?
    Horvath D; Bonachera F; Solov'ev V; Gaudin C; Varnek A
    J Chem Inf Model; 2007; 47(3):927-39. PubMed ID: 17480052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New 3D amino acid structure descriptors and its application to the polypeptide QSAR].
    Ding JJ; Ding XQ; Zhao LF; Chen JS
    Yao Xue Xue Bao; 2005 Apr; 40(4):340-6. PubMed ID: 16011263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A general method for exploiting QSAR models in lead optimization.
    Lewis RA
    J Med Chem; 2005 Mar; 48(5):1638-48. PubMed ID: 15743205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
    Tuccinardi T; Ortore G; Santos MA; Marques SM; Nuti E; Rossello A; Martinelli A
    J Chem Inf Model; 2009 Jul; 49(7):1715-24. PubMed ID: 19522467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of antibacterial compounds by machine learning approaches.
    Yang XG; Chen D; Wang M; Xue Y; Chen YZ
    J Comput Chem; 2009 Jun; 30(8):1202-11. PubMed ID: 18988254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane-interaction quantitative structure--activity relationship (MI-QSAR) analyses of skin penetration enhancers.
    Zheng T; Hopfinger AJ; Esposito EX; Liu J; Tseng YJ
    J Chem Inf Model; 2008 Jun; 48(6):1238-56. PubMed ID: 18507373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.